Alvespimycin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alvespimycin, covering 2015-11-04 to 2015-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer [Phase 2]